|
🐜
|
Clinical features and outcomes of critically ill patients with coronavirus disease 2019 (COVID-19): A multicenter cohort study
13 auth.
Khalid A. Al Sulaiman,
Ohoud A. Aljuhani,
K. Eljaaly,
A. Alharbi,
Adel M. Al Shabasy,
Alawi S. Alsaeedi,
Mashael Al Mutairi,
H. Badreldin,
Shmeylan A. Al Harbi,
Hussain Al Haji,
...
O. Al Zumai,
R. Vishwakarma,
Abdulmalik M. Alkatheri
|
5 |
2021 |
5
🐜
|
|
🐜
|
Evaluation of inhaled nitric oxide (iNO) treatment for moderate-to-severe ARDS in critically ill patients with COVID-19: a multicenter cohort study
29 auth.
Khalid A. Al Sulaiman,
G. Korayem,
A. Altebainawi,
Shmeylan A. Al Harbi,
A. Alissa,
Abdullah F. Alharthi,
Raed Kensara,
Amjaad Alfahed,
R. Vishwakarma,
Hussain Al Haji,
Naif Almohaimid,
O. Al Zumai,
Fahad Alrubayan,
Abdulmajid Asiri,
N. Alkahtani,
...
A. Alolayan,
Samiah Alsohimi,
Nawal Melibari,
Alaa Almagthali,
Seba Aljahdali,
Abeer A. Alenazi,
Alawi S. Alsaeedi,
Ghassan Al Ghamdi,
Omar Al Faris,
Joud Alqahtani,
Jalal Al Qahtani,
Khalid A. Alshammari,
K. I. Alshammari,
Ohoud A. Aljuhani
|
5 |
2022 |
5
🐜
|
|
🐜
|
The Role of Inhaled Corticosteroids (ICS) in Critically Ill Patients With COVID-19: A Multicenter, Cohort Study
24 auth.
Khalid A. Al Sulaiman,
Ohoud A. Aljuhani,
Kholoud Al Aamer,
Omar Al Shaya,
Abdulrahman I. Al Shaya,
Alawi S. Alsaeedi,
Alaa Alhubaishi,
A. Altebainawi,
Alaa Al Harthi,
Shorouq Albelwi,
...
Rahaf Almutairi,
Norah S. Alsubaie,
Alanoud A. Alsallum,
G. Korayem,
Amjaad Alfahed,
Raed Kensara,
Elaf F. Altebainawi,
Raghdah S. Alenezi,
T. Alsulaiman,
Huda Al Enazi,
R. Vishwakarma,
Tarek Al Dabbagh,
U. Bakhsh,
Ghassan Al Ghamdi
|
3 |
2021 |
3
🐜
|
|
🐜
|
The impact of HMG-CoA reductase inhibitors use on the clinical outcomes in critically ill patients with COVID-19: A multicenter, cohort study
25 auth.
Khalid A. Al Sulaiman,
Ohoud A. Aljuhani,
G. Korayem,
A. Altebainawi,
Shmeylan A. Al Harbi,
Abdulrahman I. Al Shaya,
H. Badreldin,
Raed Kensara,
Abdullah F. Alharthi,
Jahad Alghamdi,
Ahad Alawad,
R. Alotaibi,
Abdullah Kharbosh,
Hessa Al Muqati,
Abdulmohsen Alhuwahmel,
...
Mohammed Almusallam,
Ghada Albarrak,
Ibrahim Al Sulaihim,
Bader Alanazi,
B. Al-Dosari,
R. Vishwakarma,
Alawi S. Alsaeedi,
Ghassan Al Ghamdi,
H. Alkofide,
H. Al-Dorzi
|
3 |
2022 |
3
🐜
|
|
🐜
|
Clinical Features and Outcomes of Critically Ill Patients with Coronavirus Disease 2019 (COVID19): A Multicenter Cohort Study
13 auth.
K. Sulaiman,
O. A. Juhani,
Khalid Eljaaly,
A. Alharbi,
A. M. Shabasy,
Alawi S. Alsaeedi,
Mashael Al Mutairi,
H. Badreldin,
Shmeylan A. Al Harbi,
Hussain A. Al Haji,
...
Omar I. Al Zumai,
R. Vishwakarma,
Abdulmalik A Alkatheri
|
2 |
2020 |
2
🐜
|
|
🐜
|
Statins’ safety and impact on the clinical outcomes in COVID-19 critically ill patients: A Multicenter, Cohort Study
23 auth.
K. Sulaiman,
Ohoud A. Aljuhani,
G. Korayem,
A. Altebainawi,
Shmeylan A. Al Harbi,
A. Shaya,
H. Badreldin,
Raed Kensara,
A. A. Harthi,
Jahad Alghamdi,
...
Ahad Alawad,
R. Alotaibi,
Abdullah Kharbosh,
Hessa Al Muqati,
Abdulmohsen Alhuwahmel,
Mohammed Almusallam,
Ibrahim Al Sulaihim,
Bader Alanazi,
B. Al-Dosari,
R. Vishwakarma,
Alawi S. Alsaeedi,
G. Ghamdi,
H. Al-Dorzi
|
0 |
2021 |
0
🐜
|
